BrightSpring Health Services, Inc. Common Stock (BTSG)vs10X Genomics Inc (TXG)
BTSG
BrightSpring Health Services, Inc. Common Stock
$44.82
+3.49%
HEALTHCARE · Cap: $8.32B
TXG
10X Genomics Inc
$20.91
+5.55%
HEALTHCARE · Cap: $2.53B
Smart Verdict
WallStSmart Research — data-driven comparison
BrightSpring Health Services, Inc. Common Stock generates 1908% more annual revenue ($12.91B vs $642.82M). BTSG leads profitability with a 1.5% profit margin vs -6.8%. BTSG earns a higher WallStSmart Score of 54/100 (C-).
BTSG
Buy54
out of 100
Grade: C-
TXG
Avoid32
out of 100
Grade: F
Intrinsic Value Comparison
Multi-model valuation · Graham Formula
Margin of Safety
-78.4%
Fair Value
$22.46
Current Price
$44.82
$22.36 premium
Intrinsic value data unavailable for TXG.
Key Strengths & Concerns
Side-by-side fundamental analysis
Key Strengths
Revenue surging 29.3% year-over-year
No standout strengths identified
Areas to Watch
3.4% earnings growth
ROE of 5.9% — below average capital efficiency
1.5% margin — thin
Operating margin of 3.0%
0.6% revenue growth
0.0% earnings growth
ROE of -5.8% — below average capital efficiency
Currently unprofitable
Comparative Analysis Report
WallStSmart ResearchBull Case : BTSG
The strongest argument for BTSG centers on Revenue Growth. Revenue growth of 29.3% demonstrates continued momentum.
Bull Case : TXG
TXG has a balanced fundamental profile.
Bear Case : BTSG
The primary concerns for BTSG are EPS Growth, Return on Equity, Profit Margin. A P/E of 90.2x leaves little room for execution misses. Thin 1.5% margins leave little buffer for downturns.
Bear Case : TXG
The primary concerns for TXG are Revenue Growth, EPS Growth, Return on Equity.
Key Dynamics to Monitor
BTSG profiles as a growth stock while TXG is a turnaround play — different risk/reward profiles.
BTSG carries more volatility with a beta of 2.33 — expect wider price swings.
BTSG is growing revenue faster at 29.3% — sustainability is the question.
BTSG generates stronger free cash flow (174M), providing more financial flexibility.
Bottom Line
BTSG scores higher overall (54/100 vs 32/100) and 29.3% revenue growth. Both earn "Buy" and "Avoid" ratings respectively — the choice depends on your investment horizon and risk tolerance.
This analysis is generated from publicly available financial data. Not financial advice.
BrightSpring Health Services, Inc. Common Stock
HEALTHCARE · HEALTH INFORMATION SERVICES · USA
BrightSpring Health Services, Inc. (BTSG) is a leading provider of home and community-based health services, specializing in meeting the intricate needs of a diverse patient population, including individuals with intellectual and developmental disabilities as well as those requiring rehabilitation. The company emphasizes personalized care solutions backed by a highly trained workforce, ensuring exceptional patient outcomes. BrightSpring's strategic investment in technology and commitment to quality enable it to thrive in the growing market for value-based care, making it well-positioned to capitalize on the ongoing evolution of the healthcare landscape.
Visit Website →10X Genomics Inc
HEALTHCARE · HEALTH INFORMATION SERVICES · USA
10x Genomics, Inc., a life science technology company, develops and sells instruments, consumables, and software for analyzing biological systems in North America, Europe, the Middle East, Africa, China, and Asia Pacific. The company is headquartered in Pleasanton, California.
Compare with Other HEALTH INFORMATION SERVICES Stocks
Want to dig deeper into these stocks?